These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 15066465

  • 1. Early and late hormonal responses to the microdose gonadotropin-releasing hormone agonist in normal menstruating women.
    Park WI, Kim SS, Chung HR, Shin SY, Lee JY.
    Fertil Steril; 2004 Apr; 81(4):1067-72. PubMed ID: 15066465
    [Abstract] [Full Text] [Related]

  • 2. Safety and efficacy of low dose hCG for luteal support after triggering ovulation with a GnRH agonist in cases of polyfollicular development.
    Krause BT, Ohlinger R.
    Eur J Obstet Gynecol Reprod Biol; 2006 May 01; 126(1):87-92. PubMed ID: 16377065
    [Abstract] [Full Text] [Related]

  • 3. Follicular phase serum levels of luteinizing hormone do not influence delivery rates in in vitro fertilization cycles down-regulated with a gonadotropin-releasing hormone agonist and stimulated with recombinant follicle-stimulating hormone.
    Cabrera RA, Stadtmauer L, Mayer JF, Gibbons WE, Oehninger S.
    Fertil Steril; 2005 Jan 01; 83(1):42-8. PubMed ID: 15652885
    [Abstract] [Full Text] [Related]

  • 4. The serum follicle-stimulating hormone-to-luteinizing hormone ratio at the start of stimulation with gonadotropins after pituitary down-regulation is inversely correlated with a mature oocyte yield and can predict "low responders".
    Ho JY, Guu HF, Yi YC, Chen MJ, Ho ES.
    Fertil Steril; 2005 Apr 01; 83(4):883-8. PubMed ID: 15820795
    [Abstract] [Full Text] [Related]

  • 5. Subcutaneous administration of pulsatile gonadotropin-releasing hormone decreases serum follicle-stimulating hormone and luteinizing hormone levels in women with polycystic ovary syndrome: a preliminary study.
    Graña-Barcia M, Liz-Lestón J, Lado-Abeal J.
    Fertil Steril; 2005 May 01; 83(5):1466-72. PubMed ID: 15866586
    [Abstract] [Full Text] [Related]

  • 6. Microdose gonadotropin-releasing hormone agonist flare-up protocol versus multiple dose gonadotropin-releasing hormone antagonist protocol in poor responders undergoing intracytoplasmic sperm injection-embryo transfer cycle.
    Kahraman K, Berker B, Atabekoglu CS, Sonmezer M, Cetinkaya E, Aytac R, Satiroglu H.
    Fertil Steril; 2009 Jun 01; 91(6):2437-44. PubMed ID: 18555238
    [Abstract] [Full Text] [Related]

  • 7. Effects of dose and duration of continuous GnRH-agonist treatment on induction of estrus in beagle dogs: competing and concurrent up-regulation and down-regulation of LH release.
    Concannon PW, Temple M, Montanez A, Newton L.
    Theriogenology; 2006 Oct 01; 66(6-7):1488-96. PubMed ID: 16563490
    [Abstract] [Full Text] [Related]

  • 8. Oestradiol-17beta responsiveness, plasma LH profiles, pituitary LH and FSH concentrations in long-term ovariectomised Holstein cows at 24 h, 48 h and 21 days following treatment with an absorbable GnRH agonist implant.
    Padula AM, Macmillan KL.
    Anim Reprod Sci; 2005 Jan 01; 85(1-2):27-39. PubMed ID: 15556306
    [Abstract] [Full Text] [Related]

  • 9. Gonadotropin release in periovulatory heifers after GnRH analogs measured by two types of immunoassays.
    Schneider F, Bellmann A, Becker F, Bambang Poernomo S, Rehfeldt C, Nürnberg G, Kanitz W.
    Exp Clin Endocrinol Diabetes; 2002 Aug 01; 110(5):235-44. PubMed ID: 12148088
    [Abstract] [Full Text] [Related]

  • 10. A preliminary study on reduced dose (33 or 25 microg) gonadotropin-releasing hormone agonist long protocol for multifollicular ovarian stimulation in patients with high basal serum follicle-stimulating hormone levels undergoing in vitro fertilization-embryo transfer.
    Ku SY, Choi YS, Jee BC, Suh CS, Choi YM, Kim JG, Moon SY, Kim SH.
    Gynecol Endocrinol; 2005 Oct 01; 21(4):227-31. PubMed ID: 16316845
    [Abstract] [Full Text] [Related]

  • 11. A randomized controlled trial of increasing recombinant follicle-stimulating hormone after initiating a gonadotropin-releasing hormone antagonist for in vitro fertilization-embryo transfer.
    Propst AM, Bates GW, Robinson RD, Arthur NJ, Martin JE, Neal GS.
    Fertil Steril; 2006 Jul 01; 86(1):58-63. PubMed ID: 16753156
    [Abstract] [Full Text] [Related]

  • 12. Endocrine modifications associated with final oocyte maturation with gonadotropin-releasing hormone agonists vs. human chorionic gonadotropin in women undergoing intrauterine insemination.
    Díaz I, Guillén A, Pacheco A, Requena A, Garcia-Velasco JA.
    J Reprod Med; 2008 Jan 01; 53(1):33-9. PubMed ID: 18251359
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Effect of concentration of circulating luteinizing hormone in late-follicle phase on the outcome of in vitro fertilization for normogonadotrophic women].
    Sun H, Hu Y, Wang B, Chen Q, Zhang N, Chen H, Wang J, Xu Z.
    Zhonghua Nan Ke Xue; 2004 Dec 01; 10(12):912-5. PubMed ID: 15638021
    [Abstract] [Full Text] [Related]

  • 15. Clinical effects of ovulation induction with recombinant follicle-stimulating hormone supplemented with recombinant luteinizing hormone or low-dose recombinant human chorionic gonadotropin in the midfollicular phase in microdose cycles in poor responders.
    Berkkanoglu M, Isikoglu M, Aydin D, Ozgur K.
    Fertil Steril; 2007 Sep 01; 88(3):665-9. PubMed ID: 17292895
    [Abstract] [Full Text] [Related]

  • 16. [Effects of gonadotropin releasing hormone analogues on chemotherapy-induced ovarian function damage in rats].
    Peng P, Yang DZ, Zheng CY, Mo YQ, He YM, Zhang QX.
    Zhonghua Fu Chan Ke Za Zhi; 2007 Aug 01; 42(8):546-50. PubMed ID: 17983495
    [Abstract] [Full Text] [Related]

  • 17. Efficacy of gonadotropin-releasing hormone agonist and an extended-interval dosing regimen in the treatment of patients with adenomyosis and endometriosis.
    Kang JL, Wang XX, Nie ML, Huang XH.
    Gynecol Obstet Invest; 2010 Aug 01; 69(2):73-7. PubMed ID: 19923847
    [Abstract] [Full Text] [Related]

  • 18. The relationship between luteinizing hormone and estradiol secretion in female precocious puberty: evaluation by sensitive gonadotropin assays and the leuprolide stimulation test.
    Garibaldi LR, Aceto T, Weber C, Pang S.
    J Clin Endocrinol Metab; 1993 Apr 01; 76(4):851-6. PubMed ID: 8473395
    [Abstract] [Full Text] [Related]

  • 19. Estimation of the follicle-stimulating hormone (FSH) threshold for initiating the final stages of follicular development in women with elevated FSH levels in the early follicular phase.
    de Koning CH, Schoemaker J, Lambalk CB.
    Fertil Steril; 2004 Sep 01; 82(3):650-3. PubMed ID: 15374709
    [Abstract] [Full Text] [Related]

  • 20. Can pregnancy rate be improved in gonadotropin-releasing hormone (GnRH) antagonist cycles by administering GnRH agonist before oocyte retrieval? A prospective, randomized study.
    Schachter M, Friedler S, Ron-El R, Zimmerman AL, Strassburger D, Bern O, Raziel A.
    Fertil Steril; 2008 Oct 01; 90(4):1087-93. PubMed ID: 18023439
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.